Skip to main content
. 2018 Jul 24;16(4):4353–4360. doi: 10.3892/ol.2018.9198

Figure 2.

Figure 2.

Serum cfDNA concentration in NSCLC patients and normal controls. (A) Serum cfDNA concentration in 60 NSCLC patients and 27 normal controls as determined by LINE1 qPCR. (B) Comparison of serum cfDNA concentrations between NSCLC patients at different tumour stages and normal controls. *P<0.05 and ***P<0.001 indicate statistical significance. cfDNA, cell-free DNA; NSCLC, non-small cell lung cancer; LINE1, long interspersed nuclear element-1.